within Pharmacolibrary.Drugs.ATC.S;

model S01XA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Guaiazulen (guaiazulene) is a dark blue crystalline hydrocarbon derived from azulene, found in oil of guaiac and chamomile oil. It has anti-inflammatory and soothing properties and is primarily used in topical formulations for dermatological conditions, and in ophthalmic solutions for its mild anti-inflammatory effect. It is not widely used systemically and has very limited use as a modern therapeutic drug, with only rare use in some countries (not widely approved for systemic administration).</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic (PK) studies could be identified for guaiazulen in humans. The following are estimates based on physicochemical properties and its local use in ophthalmic or topical formulations.</p><h4>References</h4><ol><li><p>Durairaj, C (2017). Ocular Pharmacokinetics. <i>Handbook of experimental pharmacology</i> 242 31–55. DOI:<a href=&quot;https://doi.org/10.1007/164_2016_32&quot;>10.1007/164_2016_32</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27787714/&quot;>https://pubmed.ncbi.nlm.nih.gov/27787714</a></p></li><li><p>Ghate, D, &amp; Edelhauser, HF (2006). Ocular drug delivery. <i>Expert opinion on drug delivery</i> 3(2) 275–287. DOI:<a href=&quot;https://doi.org/10.1517/17425247.3.2.275&quot;>10.1517/17425247.3.2.275</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16506953/&quot;>https://pubmed.ncbi.nlm.nih.gov/16506953</a></p></li><li><p>Frangie, JP (1995). Clinical pharmacokinetics of various topical ophthalmic delivery systems. <i>Clinical pharmacokinetics</i> 29(2) 130–138. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199529020-00006&quot;>10.2165/00003088-199529020-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7586901/&quot;>https://pubmed.ncbi.nlm.nih.gov/7586901</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01XA01;
